Autosomal recessive early-onset Parkinson disease 6: genes and variants
Explore variant evidence for Autosomal recessive early-onset Parkinson disease 6 across 3 analyzed proteins (PINK1, PARK7, VPS13C). Linked ClinVar records include 14 pathogenic or likely pathogenic variants, 156 variants of uncertain significance and 16 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Autosomal recessive early-onset Parkinson disease 6
PINK1: Serine/threonine-protein kinase PINK1, mitochondrial
It accumulates on damaged mitochondria and recruits parkin to initiate selective mitophagy and mitochondrial quality control. Biallelic loss-of-function variants cause autosomal recessive early-onset Parkinson disease.
7 ClinVar pathogenic / likely pathogenic and 125 uncertain variants in PINK1 have source records linked to Autosomal recessive early-onset Parkinson disease 6. Association strength is not clinical gene validity.
PARK7: Parkinson disease protein 7
It supports mitochondrial quality control, redox homeostasis, and cellular responses to oxidative stress. Biallelic loss-of-function variants cause a rare autosomal recessive form of early-onset Parkinson disease.
7 ClinVar pathogenic / likely pathogenic and 28 uncertain variants in PARK7 have source records linked to Autosomal recessive early-onset Parkinson disease 6. Association strength is not clinical gene validity.
VPS13C: Intermembrane lipid transfer protein VPS13C
It forms a long bridge-like channel that transfers lipids between membranes at organelle contact sites, including those involving the endoplasmic reticulum and lysosomes. It supports organelle membrane homeostasis and mitochondrial health, and biallelic loss-of-function variants cause early-onset autosomal recessive Parkinson disease.
0 ClinVar pathogenic / likely pathogenic and 19 uncertain variants in VPS13C have source records linked to Autosomal recessive early-onset Parkinson disease 6. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Autosomal recessive early-onset Parkinson disease 6
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| PINK1 A168P | 168 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| PINK1 L347P | 347 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| PINK1 T313M | 313 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| PARK7 L101P | 101 | Pathogenic / likely pathogenic (★) | |
| PARK7 G108S | 108 | Pathogenic / likely pathogenic (★) | |
| PINK1 Q126P | 126 | Pathogenic / likely pathogenic (★) | |
| PARK7 L166P | 166 | Pathogenic / likely pathogenic | |
| PARK7 M26I | 26 | Pathogenic / likely pathogenic | |
| PARK7 R28Q | 28 | Pathogenic / likely pathogenic | |
| PARK7 E163K | 163 | Pathogenic / likely pathogenic | |
| PINK1 A217D | 217 | Protein kinase | Pathogenic / likely pathogenic |
| PINK1 H271Q | 271 | Protein kinase | Pathogenic / likely pathogenic |
| PINK1 G309D | 309 | Protein kinase | Pathogenic / likely pathogenic |
| PARK7 E64D | 64 | Pathogenic / likely pathogenic |
Which prediction tools work for Autosomal recessive early-onset Parkinson disease 6
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 96 out of 100
- MetaSVM: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 87 out of 100
- phyloP: 83 out of 100
- PolyPhen-2: 82 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 81 out of 100
- SIFT: 77 out of 100
- SpliceAI: 64 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 64 out of 100
- Pangolin: 41 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Autosomal recessive early-onset Parkinson disease 6
- Parkinson disease, also linked to PARK7, PINK1 and VPS13C
- Young-onset Parkinson disease, also linked to PARK7, PINK1 and VPS13C
Frequently asked questions
Which genes have records linked to Autosomal recessive early-onset Parkinson disease 6?
This view contains 3 analyzed proteins: PINK1, PARK7, VPS13C. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 14 pathogenic or likely pathogenic variants, 156 variants of uncertain significance and 16 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 200 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center